Regen BioPharma, Inc.
RGBP
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.00 | 300.00 | 4.60K | 69.60K | 1.80K |
| Total Receivables | 287.10K | 259.70K | 232.30K | 204.90K | 177.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00 | -- | -- | -- | -- |
| Total Current Assets | 287.60K | 260.20K | 237.10K | 274.60K | 179.10K |
|
|
|||||
| Total Current Assets | 287.60K | 260.20K | 237.10K | 274.60K | 179.10K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 287.60K | 260.20K | 237.10K | 274.60K | 196.80K |
|
|
|||||
| Total Accounts Payable | 20.60K | 20.20K | 11.00K | 1.70K | 30.50K |
| Total Accrued Expenses | 2.01M | 1.99M | 1.85M | 1.84M | 1.77M |
| Short-term Debt | 165.50K | 141.40K | 132.50K | 191.30K | 266.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 726.30K | 817.70K | 947.10K | 1.01M | 769.90K |
| Total Finance Division Other Current Liabilities | 3.25M | 2.65M | 3.87M | 3.52M | 3.17M |
| Total Other Current Liabilities | 3.25M | 2.65M | 3.87M | 3.52M | 3.17M |
| Total Current Liabilities | 6.17M | 5.62M | 6.81M | 6.56M | 6.01M |
|
|
|||||
| Total Current Liabilities | 6.17M | 5.62M | 6.81M | 6.56M | 6.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 165.50K | 141.40K | 132.50K | 191.30K | 266.30K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.17M | 5.62M | 6.81M | 6.56M | 6.01M |
|
|
|||||
| Common Stock & APIC | 16.63M | 16.52M | 16.31M | 15.63M | 15.51M |
| Retained Earnings | -22.31M | -21.67M | -22.66M | -21.69M | -21.12M |
| Treasury Stock & Other | -222.60K | -222.60K | -222.60K | -222.60K | -204.80K |
| Total Common Equity | -5.89M | -5.37M | -6.57M | -6.28M | -5.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 15.50K | 15.50K | 1.00K | 1.00K | 1.00K |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 15.50K | 15.50K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | -5.89M | -5.37M | -6.57M | -6.28M | -5.82M |
| Total Preferred Equity | 15.50K | 15.50K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.88M | -5.36M | -6.57M | -6.28M | -5.82M |
|
|
|||||